Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Reexamination Certificate
2005-07-12
2005-07-12
Richter, Johann (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
C560S155000, C560S190000, C562S590000
Reexamination Certificate
active
06916949
ABSTRACT:
This invention pertains to novel methods for the synthesis of certain nitrogen mustard prodrugs, such as N-{4-[N,N-bis(2-haloethylamino)-phenoxycarbonyl}-L-glutamic acid:wherein: X2is a halo group, and is —F, —Cl, —Br, or —I; n is an integer from 0 to 4; and, each RAis an aryl substituent. The methods comprise, at least, the steps of: glutamate conjugation (GC); silyloxy deprotection (SD); and, sulfonic esterification (SU). Certain preferred methods comprise the steps of: amine substitution (AS); silyloxy protection (SP); phenolic deprotection (PD); activation (AC); glutamate conjugation (GC); silyloxy deprotection (SD); sulfonic estenfication (SU); halogenation (HL); glutamate deprotection (GD); and glutamic acid protection (GP).
REFERENCES:
patent: 5587161 (1996-12-01), Burke et al.
patent: 6737541 (2004-05-01), Siedlecki et al.
patent: WO 94/02450 (1994-01-01), None
patent: 94/02450 (1994-02-01), None
patent: WO 94/25429 (1994-11-01), None
patent: WO 96/03515 (1996-02-01), None
patent: 96/20169 (1996-07-01), None
patent: WO 96/20169 (1996-07-01), None
patent: WO 98/51787 (1998-11-01), None
Springer et al. J. Med. Chem. 1995, 38, 5051-5065.
Blakey, D.C., et al., 1996, “ZD2767, an Improved System for Antibody-directed Enzyme Prodrug Therapy That Results in Tumor Regressions in Colorectal Tumor Xenografts,”Cancer Research, vol. 56, pp. 3287-3292.
Corey, E.J., et al., 1972, “Protection of Hydroxyl Groups as tert-Butyldimethylsilyl Derivatives,”J. Am. Chem. soc., vol. 94, pp. 6190-6191.
Everett, J.L. and Ross, W.C.J., 1949, “420: Aryl-2-halogeno-alkylamines, Part II,”J. Chem. Soc., pp. 1972-1983.
Ferenz, C. R., et al., 1989, “Improved Conventional Synthesis for 14C-Labeled Polyglutamates of Folic Acid,”Journal of Labelled Compounds&Radiopharmaceuticals, vol. 27, no. 7, pp. 737-751.
Greene, T.W., and Wuts, P.G.M., 1999, “Protection for Phenols and Catechols,”Protective Groups in Organic Chemistry, 3rd Edition, pp. 246-292, published by John Wiley & Sons.
Greene, T.W., and Wuts, P.G.M., 1999, “Protection for the Hydroxyl Group, Including 1,2- and 1,3-Diols: Silyl Ethers,”Protective Groups in Organic Chemistry, 3rd Edition, pp. 113-148, published by John Wiley & Sons.
Greene, T.W., and Wuts, P.G.M., 1999, “Protection for the Carboxyl Group: Ethers,” inProtective Groups in Organic Chemistry, 3rd Edition, pp. 369-328, published by John Wiley & Sons.
Hagermann, H., 1983, Kohlensaure-derivative, inHouben-Weyl Methoden der Organische Chemie: Kohlensäure Derivate(editior: H Hagermann), vol. E4, 1395 pp., published by Georg Thieme Verlag (Stuttgart, New York).
Pawlenko, S., 1985, “e) Sulfonsäure-ester, el) sulfonsäure-organoester,” in inHouben-Weyl Methoden der Organische Chemie: Organische Schwefel-Verbindungen: Tiel 2(editor: D Klamann), vol. E11, Part 2, pp. 1084-1094, published by Georg Thieme Verlag (Stuttgart, New York).
Lalonde et al., 1985, “Use of Organosilicon Reagents as Protective Groups in Organic Synthesis,”Synthesis, 1985, pp. 817-845.
March, J., 1992,Advanced Organic Chemistry, 4th edition, “O-66: Formation of Alkyl Halides from Esters of Sulfuric and Sulfonic Acids, Halo-de-sulfonyloxy-substitution, etc.,” p. 431, published by John Wiley & Sons (New York, USA).
Periasamy, M.P., et al., 1979, “Isocyanides in Organic Synthesis: A Review,”Org. Prep. Proceed. Int., vol. 11, No. 6, pp. 293-311.
Raucher, S., et al., 1985, “A Convenient Method for the Conversion of Amines to Carbamates,”Synthetic Communications, vol. 15, No. 11, pp. 1025-1031.
Springer, C.J., et al., 1995, “Optimization of Alkylating Agent Prodrugs Derived from Phenol and Aniline Mustards: A New Clinical Candidate Prodrug (ZD2767) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT),”Journal of Medicinal Chemistry, vol. 38, pp. 5051-5065.
Springer et al; “Optimization of Alkylating Agent Prodrugs Derived from Phenol and Aniline Mustards: A New Clinical Candidate Prodrug (ZD2767) for Antibody-Directed Enzyme Prodrug Therapy”; J. Med. Chem., 1995, vol. 38, no. 26, pp. 5051-5065m XO000986027.
Niculescu-Duvaz Dan
Springer Caroline Joy
Cancer Research Technology Limited
Nixon & Vanderhye P.C.
Puttlitz Karl
Richter Johann
LandOfFree
Methods of chemical systhesis of phenolic nitrogen mustard... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of chemical systhesis of phenolic nitrogen mustard..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of chemical systhesis of phenolic nitrogen mustard... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3368539